BACKGROUND:Repetitive transcranial magnetic stimulation (rTMS) of frontal brain regions is under study as a non-invasive method in the treatment of affective disorders. Recent publications provide increasing evidence that rTMS may be useful in treating schizophrenia. Results are most intriguing, demonstrating a reduction of negative symptoms following high-frequency rTMS. In this context, disentangling of negative and depressive symptoms is of the utmost importance when understanding specific rTMS effects on schizophrenic symptoms. METHOD: Using a sham-controlled parallel design, 20 patients with schizophrenia were included in the study. Patients were treated with high-frequency 10Hz rTMS over 10 days. Besides clinical ratings, ECD-SPECT (technetium-99 bicisate single photon emission computed tomography) imaging was performed before and after termination of rTMS treatment. RESULTS:High-frequency rTMS leads to a significant reduction of negative symptoms combined with a trend for non-significant improvement of depressive symptoms in the active stimulated group as compared with the sham stimulated group. Additionally, a trend for worsening of positive symptoms was observed in the actively treated schizophrenic patients. In both groups no changes in regional cerebral blood flow could be detected by ECD-SPECT. CONCLUSIONS: Beneficial effects of high-frequency rTMS on negative and depressive symptoms were found, together with a trend for worsening positive symptoms in schizophrenic patients.
RCT Entities:
BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) of frontal brain regions is under study as a non-invasive method in the treatment of affective disorders. Recent publications provide increasing evidence that rTMS may be useful in treating schizophrenia. Results are most intriguing, demonstrating a reduction of negative symptoms following high-frequency rTMS. In this context, disentangling of negative and depressive symptoms is of the utmost importance when understanding specific rTMS effects on schizophrenic symptoms. METHOD: Using a sham-controlled parallel design, 20 patients with schizophrenia were included in the study. Patients were treated with high-frequency 10 Hz rTMS over 10 days. Besides clinical ratings, ECD-SPECT (technetium-99 bicisate single photon emission computed tomography) imaging was performed before and after termination of rTMS treatment. RESULTS: High-frequency rTMS leads to a significant reduction of negative symptoms combined with a trend for non-significant improvement of depressive symptoms in the active stimulated group as compared with the sham stimulated group. Additionally, a trend for worsening of positive symptoms was observed in the actively treated schizophrenicpatients. In both groups no changes in regional cerebral blood flow could be detected by ECD-SPECT. CONCLUSIONS: Beneficial effects of high-frequency rTMS on negative and depressive symptoms were found, together with a trend for worsening positive symptoms in schizophrenicpatients.
Authors: Arielle D Stanford; Cheryl Corcoran; Peter Bulow; Sarah Bellovin-Weiss; Dolores Malaspina; Sarah H Lisanby Journal: J ECT Date: 2011-03 Impact factor: 3.635
Authors: Joachim Cordes; P Falkai; B Guse; A Hasan; T Schneider-Axmann; M Arends; G Winterer; W Wölwer; E Ben Sliman; M Ramacher; C Schmidt-Kraepelin; C Ohmann; B Langguth; M Landgrebe; P Eichhammer; E Frank; J Burger; G Hajak; M Rietschel; T Wobrock Journal: Eur Arch Psychiatry Clin Neurosci Date: 2009-11 Impact factor: 5.270
Authors: Stephen J Brandt; Halimah Y Oral; Carla Arellano-Bravo; Martin H Plawecki; Tom A Hummer; Michael M Francis Journal: Neurotherapeutics Date: 2021-04-12 Impact factor: 7.620